Squarepoint
CNTB icon

Squarepoint’s Connect Biopharma Holdings CNTB Stock Holding History

Squarepoint’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$47.3K Buy
+42,972
New +$87.8K ﹤0.01% 4294

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Koa Wealth Management
Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SmartHarvest Portfolios
SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Squarepoint's CNTB Position: Q3 2026 in Review

Squarepoint opened a new position in Connect Biopharma Holdings (CNTB) in Q3 2026: 42,972 shares worth $47.3K. The stake represents ﹤0.01% of the portfolio and ranks #4294 among its holdings.

17 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

  • Squarepoint held 42,972 shares of Connect Biopharma Holdings worth $47.3K as of Q3 2026.
  • Connect Biopharma Holdings was a new Squarepoint position in Q3 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4294 holding.
  • 17 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.